The tariff classification of Valganciclovir Hydrochloride Tablets in dosage form, from Italy
Issued February 28, 2018 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9210
Headings: 3004
Product description
Valganciclovir Hydrochloride, imported in tablet form of 450 mg, is an antiviral medication used for the treatment of cytomegalovirus infection in those with HIV/AIDS or following organ transplant.
CBP rationale
The applicable subheading for Valganciclovir HydrochlorideTablets in dosage form will be 3004.90.9210, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Other.
Full text
N293921 February 28, 2018 CLA-2-30:OT:RR:NC:N1:138 CATEGORY: Classification TARIFF NO.: 3004.90.9210 Ms. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road Cork, T12 XN72, Ireland RE: The tariff classification of Valganciclovir Hydrochloride Tablets in dosage form, from Italy Dear Ms. Keeler: In your letter dated January 30, 2018, you requested a tariff classification ruling. Valganciclovir Hydrochloride, imported in tablet form of 450 mg, is an antiviral medication used for the treatment of cytomegalovirus infection in those with HIV/AIDS or following organ transplant. The applicable subheading for Valganciclovir HydrochlorideTablets in dosage form will be 3004.90.9210, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Anti-infective medicaments: Other." The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of various pharmaceutical products packed for retail sale from India
The tariff classification of Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in dosage form and Droxidopa Capsules in dosage form, from India
The tariff classification of Niclosamide Tablets in dosage form
The tariff classification of Hydroxychloroquine Sulfate Tablets in dosage form, from India
The tariff classification of Nitrofurantoin Capsules USP (monohydrate/macrocrystals) in dosage form, from Taiwan
The tariff classification of Dapsone 5% Gel in dosage form, from Canada
The tariff classification of Ketoconazole 2% Cream in dosage form, from Canada
The tariff classification of Albendazole Tablets in dosage form, from Mexico
The tariff classification of Acyclovir Sodium Injection and Acetazolamide Tablets in dosage form, from India
The tariff classification of Atovaquone Oral Suspension in dosage form, from India
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →